Hirsch Stanley 4
4 · Foamix Pharmaceuticals Ltd. · Filed Oct 17, 2019
Insider Transaction Report
Form 4
Hirsch Stanley
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2019-10-15$0.62/sh+90,000$55,800→ 150,000 total(indirect: See footnote) - Exercise/Conversion
Options
2019-10-15−90,000→ 32,500 total(indirect: See footnote)Exercise: $0.62From: 2004-01-01Exp: 2019-11-25→ Ordinary Shares (90,000 underlying)
Holdings
- 69,365
Ordinary Shares
Footnotes (2)
- [F1]Securities are held by ZEAS Technology and Science Management Ltd., a company beneficially owned by Stanley Hirsch.
- [F2]This security represents ordinary shares and restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.